Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Renal function Stories

2011-12-09 12:17:24

Clinicians should strive to identify and treat kidney injury patients who need care Most patients with an abrupt kidney injury that does not get better do not see a kidney specialist within a year, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The findings indicate that efforts are needed to identify and treat kidney injury patients who require subsequent care. Acute kidney injury (AKI), an abrupt or rapid decline in kidney...

2011-12-08 08:00:00

MADISON, N.J., Dec. 8, 2011 /PRNewswire/ -- One in three first-time participants in a company-sponsored, lab-based wellness program were not aware they were at high risk for a serious medical condition, according to an article published today in the peer-reviewed journal PLoS ONE. The study by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, found that 36 percent of first-time participants in lab-based wellness programs...

2011-12-05 13:01:24

Damage to podocytes -- a specialized type of epithelial cell in the kidney -- occurs in more than 90 percent of all chronic kidney disease. Now researchers at the Stanford University School of Medicine have uncovered an unexpected pathway that reveals for the first time how these cells may regenerate and renew themselves during normal kidney function. This finding is an important step toward one day therapeutically coaxing the cells to divide, which could be used to treat people with...

2011-11-21 06:52:48

(Ivanhoe Newswire) — Impaired glomerular filtration rate (GFR) in the kidney leads to end-stage renal disease and increases the risk of cardiovascular disease and death. Patients with Type I diabetes are at an increased for kidney disease, but there are no interventions that have proved to prevent impaired GFR in these people. According to this study, intensive diabetes therapy may prevent kidney disease in type I diabetes patients. In the Diabetes Control and Complications Trial...

2011-11-14 15:05:00

EAST NORRITON, Pa., Nov. 14, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN) today provided a business update, including announcement of a restructuring plan, and reported its financial results for the third quarter ended September 30, 2011. The restructuring plan is designed to fund the Company's lead development programs through key milestones in 2012 while reducing the Company's anticipated cash utilization. As a result of this restructuring, the Company expects to have sufficient...

2011-11-14 11:20:34

Years later participants see benefits of good blood sugar control in reducing slow-progressing complications Maintaining good glucose control early in the course of type 1 diabetes could lessen the long-term risk of kidney disease, as measured by a common test of kidney function. This finding comes from more than two decades of research on preventing life-shortening complications of type 1 diabetes. The National Institutes of Health (NIH) funded the longitudinal study. Results will be...

2011-11-14 11:16:40

Anticipated dialysis clinic closures could compromise care; New initiative hopes to improve Americans' kidney health Highlights:     Medicare will soon reduce reimbursements to some dialysis facilities, which may lead to closures. Patients will have to drive further to get care at other facilities, which could compromise their health.     The Healthy People initiative provides 10-year national objectives for improving the health of all Americans. Healthy...

2011-11-08 07:20:00

NEWTOWN SQUARE, Pa., Nov. 8, 2011 /PRNewswire/ -- Kibow Biotech, Inc. (a suburban Philadelphia-based Company) announced today, at the occasion of Renal Week, it is changing the brand name of its flagship product to "RENADYL(TM)." Formerly known as Kibow® Biotics, this patented and clinically tested probiotic formulation helps maintain healthy kidney function. At a time when there is growing recognition of the scientific and health benefits of probiotics, Kibow has opted...

2011-11-07 06:00:00

CAPE CORAL, Fla., Nov. 7, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV) announced that it has executed the formal closing documents and acquired the chronic kidney disease (CKD) formula. This formula was developed to restore proper kidney function. Chronic kidney disease (CKD) is a growing health problem in the United States. A report by the Centers for Disease Control (CDC) determined that 16.8% of all adults above the age of 20...

2011-11-01 15:01:00

CAPE CORAL, Fla., Nov. 1, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk) announced that it will purchase the exclusive rights to a formula that was developed to restore proper kidney function in people with chronic kidney disease (CKD). Chronic kidney disease is a growing health problem in the United States. A report by the Centers for Disease Control (CDC) determined that 16.8% of all adults above the age of 20 years have chronic...